The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Amendment etc.) (EU Exit) Regulations 2019

This section has no associated Explanatory Memorandum

13.—(1) Article 1 is amended as follows.U.K.

(2) In paragraph 1—

(a)in the first sentence, omit “as well as the free movement of substances, mixtures and articles as referred to in Article 4(8)”;

(b)in point (a), for “harmonising” substitute “ establishing ”;

(c)in point (d), for “harmonised classifications and labelling elements at Community level in Part 3 of Annex VI” substitute “ mandatory classifications and labelling elements in the [F1GB] mandatory classification and labelling list ”;

(d)in point (e), for “classification and labelling inventory of substances, which is made up of all notifications, submissions and harmonised classification and labelling elements referred to in points (c) and (d)” substitute “ [F2GB] notification database of substances notified to the Agency after [F3IP completion day] ”.

(3) In paragraph 2—

(a)in point (a), for “Council Directive 96/29/Euratom of 13 May 1996” substitute “ the Ionising Radiations Regulations 2017 M1 F4... ”;

(b)in point (d), omit “Community”.

(4) In paragraph 3, for “Directive 2006/12/EC of the European Parliament and of the Council of 5 April 2006” substitute “ Directive 2008/98/EC of the European Parliament and of the Council of 19 November 2008 ”.

(5) Omit paragraph 4.

(6) In paragraph 5—

(a)in point (a), for “Directive 2001/83/EC” substitute “ the Human Medicines Regulations 2012 M2 ”;

(b)in point (b), for “Directive 2001/82/EC” substitute “ the Veterinary Medicines Regulations 2013 M3 ”;

(c)in point (c), for “Directive 76/768/EEC” substitute “ Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products ”;

(d)for point (d), substitute—

“(d)medical devices as defined in the Medical Devices Regulations 2002 M4 which are invasive or used in direct physical contact with the human body, and in vitro diagnostic medical devices, as defined in the same regulations.”;

(e)in point (e)—

(i)in paragraph (i), for “Directive 89/107/EEC” substitute “ Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives ”;

(ii)in paragraph (ii), for “Directive 88/388/EEC and Decision 1999/217/EC” substitute “ Regulation (EC) No 1334/2008 of the European Parliament and of the Council of 16 December 2008 on flavourings and certain food ingredients with flavouring properties for use in and on foods or Commission implementing Regulation (EU) No 872/2012 of 1 October 2012 adopting the list of flavouring substances provided for by Regulation (EC) 2232/96 of the European Parliament and of the Council, introducing it in Annex I to Regulation (EC) No 1334/2008 of the European Parliament and of the Council and repealing Commission Regulation (EC) No 1565/2000 and Commission Regulation 1999/217/EC ”;

(iii)in paragraph (iv), for “Directive 82/471/EEC” substitute “ Regulation (EC) No 767/2009 of the European Parliament and of the Council of 13 July 2009 on the placing on the market and use of feed ”.

Textual Amendments

Commencement Information

I1Sch. 2 para. 13 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1(2)

Marginal Citations

M1S.1. 2017/1075.